Plain-English translation of NCT05732727 on ClinicalTrials.gov ↗ ·
Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.
This trial is testing a new approach to controlling high blood pressure in people with moderate to severe chronic kidney disease. Instead of the usual way doctors add more blood pressure medicines, this study tests whether using diuretics (water pills) as the second medication works better. The goal is to see if this medication strategy reduces heart attacks, strokes, kidney failure, and death better than standard care.
High blood pressure is the leading cause of serious complications in people with kidney disease, but doctors don't have clear guidelines on which medications work best as the second line of treatment. Research suggests that many people with kidney disease and uncontrolled blood pressure have excess fluid in their bodies, and this medication approach may address that root problem more effectively than current standard practice.
You likely qualify if…
You likely don't qualify if…
If you join this study, your doctor will place you in either the new diuretic-based treatment group or the standard care group. The new group will follow a specific algorithm for adding or adjusting water pill medications to your current blood pressure treatment, while the standard group receives usual care as your doctor normally provides. You will have regular clinic visits to monitor your blood pressure, kidney function, and overall health over the study period.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
France